August 19, 2020 -- Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization for biologics, viral vaccines, and gene therapies, held a virtual groundbreaking ceremony on August 19 for its Advanced Therapies Innovation Center construction project in Texas.
The $55 million, 60,000-sq-ft facility is being constructed in College Station and will house dedicated process development and innovation laboratories. The labs will have biosafety level 2 capabilities with advanced upstream, downstream, and analytical development technologies. The building is part of a 22-acre parcel acquired by Fujifilm in June 2020.
The facility will triple the company's advanced therapies and process development capabilities and help the company provide end-to-end gene therapy solutions from preclinical to commercial launch. It is expected to be operational in the fall of 2021.
Copyright © 2020 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
